Long-Term Outcomes of Previously Treated Adult and Adolescent Patients with Severe Hemophilia A Receiving Prophylaxis with Extended Half-Life FVIII Treatments: An Economic Analysis from a United…

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, January 2021

Altmetric Badge

Mentioned by

facebook: 1 Facebook page

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 24 Mendeley

Summary Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Haemophilia News, 31 Jan 2021

PDF | Background: The standard of care for patients with hemophilia A is prophylaxis with factor VIII (FVIII) therapies.